NCT00560326View on ClinicalTrials.gov

Tacrolimus Ointment Long Term Safety in Young Children With Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

December 31, 2006

Conditions
Dermatitis, Atopic
Interventions
DRUG

Tacrolimus Ointment 0.03%

Once or twice daily topical application

Trial Locations (8)

Unknown

Halifax

Vancouver

Waterloo

Helsinki

Drogheda

Dublin

Riga

London

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY